10-Q: Callan JMB Reports Wider Loss, Revenue Dip in Q2 2025

Callan JMB Inc. posted a significantly increased net loss for the second quarter and first half of 2025, primarily due to decreased specialty packaging revenue and a substantial rise in administrative expenses.

Summary

• Net loss for the six months ended June 30, 2025, widened significantly to $(2,641,986) from $(193,609) in the prior year.
• Revenue for the six months decreased by 17% to $3,115,687 from $3,776,289 year-over-year.
• Selling, general, and administrative expenses more than doubled, increasing by 105% to $3,901,878 for the six months.
• Cash and cash equivalents increased to $4,224,151 as of June 30, 2025, from $2,097,945 at December 31, 2024, largely due to IPO proceeds.
• The company completed its Initial Public Offering (IPO) in February 2025, raising approximately $4.7 million in net proceeds.
• Subsequent to the quarter, Callan JMB entered into an agreement to potentially sell up to $25.0 million of common stock to an investor.

Sentiment

Score: 3

Explanation: The company reported a substantial increase in net loss and a significant decline in revenue, coupled with a more than doubling of administrative expenses. While the recent IPO and a potential future capital raise provide liquidity, the underlying operational performance and identified internal control deficiencies indicate significant challenges and a negative financial trajectory.

Positives

• Successfully completed an Initial Public Offering (IPO) in February 2025, raising approximately $4.7 million in net proceeds.
• Cash and cash equivalents increased significantly to $4,224,151 as of June 30, 2025, from $2,097,945 at December 31, 2024, enhancing liquidity.
• Entered into a Purchase Agreement on July 24, 2025, providing the right to sell up to $25.0 million of common stock, offering a potential future capital infusion.
• Emergency preparedness revenue saw a slight increase for the six months ended June 30, 2025, to $2,072,710 from $2,053,541.

Negatives

• Net loss for the six months ended June 30, 2025, significantly widened to $(2,641,986) from $(193,609) in the prior year, an increase of 1264%.
• Total revenue decreased by 17% to $3,115,687 for the six months ended June 30, 2025, compared to $3,776,289 in the prior year.
• Gross profit declined by 25% to $1,256,963 for the six months ended June 30, 2025, from $1,679,799 in the prior year.
• Selling, general, and administrative expenses surged by 105% to $3,901,878 for the six months, primarily due to increased consulting, professional, marketing, advertising, and stock-based compensation costs.
• Cash used in operating activities increased substantially to $(2,124,970) for the six months ended June 30, 2025, compared to cash provided of $275,524 in the prior year.
• Specialty packaging revenue decreased significantly by 39% for the six months ended June 30, 2025, to $1,042,977 from $1,722,748.
• Non-governmental customer revenue decreased by 52% for the six months ended June 30, 2025, to $780,435 from $1,611,653.

Risks

• Concentration of credit risk with a few large customers, with Customer 1 accounting for 58% of revenue and 37% of accounts receivable for the six months ended June 30, 2025.
• Internal control deficiencies identified, including a lack of written documentation for some internal control policies and procedures, and incomplete segregation of duties within accounting functions.
• The company has exceeded the permissible number of shares to be issued under the 2024 Equity Incentive Plan by 200,000 share awards, requiring an amended Form S-8 filing.
• Reliance on government contracts for a significant portion of revenue, which can be subject to demand fluctuations.
• The potential future sale of up to $25.0 million of common stock to an investor could lead to significant dilution for existing shareholders.

Future Outlook

The company anticipates seasonal variations in operations, with revenue typically highest in the third and fourth calendar quarters and lowest in the first and second quarters. Operating expenses are also expected to be higher during winter months due to potential adverse weather conditions impacting waste collection and increasing labor/operational costs.

Management Comments

• Our strategy involves leveraging our core competitive strengths to develop and maintain ongoing relationships with a diversified group of customers while continuing to grow our service lines, ensuring that we can meet our customers changing needs.
• We strive to be recognized as the premier provider of logistics and fulfillment of a broad range of value-added services based upon the breadth of those services, quality, responsiveness, customer service, information technologies, safety, and cost effectiveness.
• We view our solutions as disruptive to the older technologies of dry ice and liquid nitrogen, in that our solutions are comprehensive and combine our competencies in configurations that are customized to our clients requirements.

Industry Context

Callan JMB operates in the specialized logistics and fulfillment sector, focusing on thermal management solutions for the life sciences industry. The company aims to disrupt traditional cold chain methods like dry ice and liquid nitrogen with its advanced predictive technology, ensuring product integrity for sensitive commodities such as personalized medicine, vaccines, and cell therapies. The industry demands high reliability, precision, and environmental responsibility, areas where Callan JMB positions its comprehensive solutions.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Settled a lawsuit with a vendor for $240,800 in February 2025, related to a prior year breach of contract claim.

Related Party Transactions

• Pays $9,800 per month to Outlaw Run Ranch (ORR) for rent expense, a related party by virtue of common ownership.
• Leases headquarters, warehouse, equipment, and a box truck for $15,425 per month from Warehouse Asset Management, a related party by virtue of common ownership.
• Awarded 100,000 stock options to the CEO's son as compensation for prior period services, with 12,500 options vested as of June 30, 2025.

Stakeholder Impact

• Shareholders: Significant dilution risk from the potential $25.0 million equity raise and existing stock-based compensation plans. Increased net loss and negative operating cash flow could negatively impact share value.
• Employees: Stock-based compensation is a significant component, potentially impacting employee motivation and retention, especially with vesting conditions.
• Customers: Decreased demand for emergency preparedness services from certain states and local governments, and a significant drop in specialty packaging revenue, indicates challenges in customer acquisition or retention.
• Creditors: Increased cash from IPO and potential future capital raise improves short-term liquidity, but widening losses and negative operating cash flow could raise concerns about long-term solvency without sustained operational improvement.

Next Steps

• File an amended Form S-8 to register shares for the over-allotment under the 2024 Equity Incentive Plan.
• Potentially utilize the Purchase Agreement to sell up to $25.0 million of common stock to an investor, subject to market conditions and company discretion.
• Address identified internal control deficiencies related to lack of written documentation and incomplete segregation of duties.

Key Dates

Recommendation

The company's financial performance for the first half of 2025 was poor, marked by a substantial increase in net loss and a significant decline in revenue, particularly in specialty packaging and non-governmental segments. Operating cash flow is negative, and internal control deficiencies were noted. However, the recent IPO provided a significant cash infusion, and the subsequent agreement to potentially raise an additional $25.0 million offers a lifeline for liquidity and future operations. Given the severe operational challenges but also the enhanced capital position and strategic efforts to secure funding, a 'hold' recommendation is appropriate for existing investors to monitor the effectiveness of the capital deployment and any improvements in operational efficiency and revenue generation. New investors should exercise extreme caution due to the current financial trajectory and governance concerns.

Keywords

Logistics, Cold Chain, Supply Chain, Thermal Management, Life Sciences, Emergency Preparedness, Specialty Packaging, SEC Filing, 10-Q, IPO, Capital Raise, Corporate Governance, Financial Performance